2BB score and signals
Bionano Genomics, Inc.’s current 2BB score is 37 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 48 | Moderate |
| Momentum | 56 | Stable |
| Financial strength | 16 | Very Weak |
| Quality | 79 | Strong |
| Risk | 67 | High |
Company facts
| CEO | Erik Holmlin |
| Headquarters | San Diego, California, United States |
| Founded | 2003 |
| Employees | 96 |
| 52-week range | $1.00 – $2.23 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-22 | — | -0.4539 | — | $9.52M |
| 2026-11-11 | — | -0.4998 | — | $8.59M |
| 2026-08-10 | -0.64 | -0.6987 | $8.17M | $7.63M |
| 2026-05-13 | -0.76 | -0.969 | $6.69M | $6.70M |
Related companies
